Associated Papers
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.
Yazaki S et al.
Ebiomedicine, 2025
40403695 (PubMed )
Supplement: mmc1.xlsx › Table_S6
Pan-cancer landscape of homologous recombination deficiency.
Nguyen L et al.
Nature Communications, 2020
33149131 (PubMed )
Supplement: 41467_2020_19406_MOESM7_ESM.xlsx › hgvs_c
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
Konecny M et al.
Breast Cancer Research and Treatment, 2011
Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population.
Alharbi KK et al.
Genome Research, 2005
MYC is amplified in BRCA1-associated breast cancers.
Grushko TA et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2004
CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q.
Nathanson KL et al.
Human Molecular Genetics, 2002
Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.
Peto J et al.
Journal of the National Cancer Institute, 1999
Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening.
Andersen TI et al.
Human Mutation, 1998
Select a paper to view details